RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.

RP 59500 is a new injectable streptogramin composed of two synergistic components (quinupristin and dalfopristin) which are active against a number of erythromycin-susceptible and -resistant gram-positive bacteria. The following experiments investigate the ability of RP 59500 to prevent experimental...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: L'Hériteau, F, Entenza, J M, Lacassin, F, Leport, C, Glauser, M P, Moreillon, P
Format: Artigo
Jezik:Inglês
Izdano: 1995
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC162756/
https://ncbi.nlm.nih.gov/pubmed/7492079
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki